Metabolomics and surgical oncology: Potential role for small molecule biomarkers
- 28 December 2010
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 103 (5), 451-459
- https://doi.org/10.1002/jso.21831
Abstract
Metabolomics, the newest of the “omics” sciences, has brought much excitement to the field of oncology as a potential new translational tool capable of bringing the molecular world of cancer care to the bedside. While still early in its development, metabolomics could alter the scope and role of surgery in the multidisciplinary treatment of cancer. This review examines potential roles of metabolomics in areas of early cancer detection, personalized therapeutics and tumorigenesis. J. Surg. Oncol. 2011; 103:451–459.This publication has 67 references indexed in Scilit:
- Metabolomics: Moving to the ClinicJournal of Neuroimmune Pharmacology, 2009
- Clinical Applications of Metabolomics in Oncology: A ReviewClinical Cancer Research, 2009
- New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancerAnnals of Oncology, 2007
- The use of metabolomics for the discovery of new biomarkers of effectToxicology Letters, 2007
- Metabolomics of a SuperorganismJournal of Nutrition, 2007
- Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline TumorsCancer Research, 2006
- Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: Clinical and laboratory aspectsClinical Biochemistry, 2006
- Peer Reviewed: So What’s the Deal with Metabonomics?Published by American Chemical Society (ACS) ,2003
- Genomic scale profiling of nutrient and trace elements in Arabidopsis thalianaNature Biotechnology, 2003
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999